1. Completed
Loading page
Mainboard
Mainboard issue. Listed.
Source: IPO Guru Pro
Company information, issue size, price band, lot size, minimum investment, and the dates published for this issue.
Anthem Biosciences Limited was incorporated in 2006. It is a contract research, development and manufacturing organisation. Its operations cover drug discovery, development and manufacturing for emerging biotech firms and large pharmaceutical companies. The company also makes fermentation-based active ingredients. These include probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. On 30 September 2024 it had 196 projects. In the six months to that date it made active ingredients and intermediates for ten commercial molecules, all supported since discovery. The IPO was entirely an offer for sale of Rs 3,395 crore, so the company received no money from it.
Current premium in rupees, the derived percentage, and the indicative price. History shows observed readings only. A missing premium is unavailable, not ₹0.
Grey Market Premium (GMP) is an unofficial market indicator and is not published by stock exchanges. Estimated listing values are illustrative, may change, and should not be considered a forecast or investment recommendation.
Subscription is shown in times subscribed. A missing multiple stays unavailable. A published zero is 0x.
Last updated: Unavailable
Last updated: Unavailable
Source: IPO Guru Pro Data by IPO Guru
History retrieved: 10 Nov 2026, 4:30 PM IST
No day-wise subscription history is loaded. Missing days are left blank and are not plotted as zero.
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 4:30 PM IST.
Revenue and profit are in rupees for each reporting period. Assets, liabilities, and ratios use the source unit when the statement includes them. Missing figures stay blank.
| Metric (Rs. Crore) | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Total Income | 1,930.29 | 1,483.07 | 1,133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
Results may still be pending. Check Allotment opens the registrar allotment portal. You may need to select this IPO there. Sign-in is not required.
This is the actual change from the issue price to the listing price. It is separate from the unofficial GMP estimate. A missing price stays unavailable.
RHP, DRHP, and other links that passed the official address check. Unverified addresses are left out.
Data by IPO Guru · Updated
Anthem Biosciences is a contract research, development and manufacturing company serving biotech and large pharmaceutical customers worldwide. It had 196 projects on 30 September 2024.
Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj
1. Completed
2. Completed
3. Completed
4. Completed
Refund
Demat credit
Indicative only. A GMP-implied price is not a guaranteed listing price.
Unofficial grey-market premium in rupees. Missing observations are not connected and are not drawn as ₹0. This chart is not the listing gain.
High unavailable · Low unavailable
Tap a point for its rupee amount, percentage, and IST time. The table lists the same observations.
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 4:30 PM IST.
| Observed (IST) | GMP (₹) | GMP % | Mark |
|---|---|---|---|
| 21 Jul 2025, 12:00 PM IST | ₹170 | +29.82% | None |
No intraday GMP history is loaded. Missing slots are not filled in.
High unavailable · Low unavailable
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 4:30 PM IST.
| EBITDA | 683.78 | 519.96 | 446.05 |
| NET Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Reserves and Surplus | 2,298.05 | 1,815.39 | 1,628.88 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |